HMGCR:恶性瘤中心 - 癌症诊断和治疗的前沿领域
Yisong Yang1, Yiting Liu1, Teng Zou1
1Engineering Technology Research Center for Functional Component Utilization of Organic Natural Products, Medical College, Dalian University, Dalian, Liaoning, China.
Frontiers in oncology
|December 26, 2025
概括
胆固醇合成酶HMG-CoA减少酶 (HMGCR) 驱动瘤生长和免疫逃避. 准HMGCR-TNF-α轴为增强癌症治疗提供了一种新的策略.
科学领域:
- 生物化学 生物化学
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
背景情况:
- 在大多数瘤中,胆固醇代谢被上调.
- HMG-CoA减少酶 (HMGCR) 对瘤生长,新陈代谢重编程和免疫规避至关重要.
- HMGCR提供胆固醇和异oprenoids,调节关键通路 (河马,刺,MAPK),并影响铁亡.
- 在HMGCR和TNF-α之间存在双向关系,影响炎症和免疫反应.
研究的目的:
- 探索HMGCR在瘤生长和瘤微环境中的作用.
- 为了研究HMGCR和TNF-α在癌症中的相互作用.
- 确定针对HMGCR-TNF-α轴的新型治疗策略.
主要方法:
- 对有关HMGCR,胆固醇代谢和癌症的现有文献的综述.
- 对HMGCR在瘤进展中的调节机制的分析.
- 检查HMGCR和TNF-α信号通路之间的相互作用.
主要成果:
- 通过提供必要的代谢物和调节关键信号通路,HMGCR显著促进瘤生长.
- HMGCR通过重塑瘤微环境来影响瘤免疫逃避.
- 作为HMGCR抑制剂,他类药物表现出抗瘤作用,但面临临临床挑战.
- HMGCR-TNF-α轴在癌症炎症和免疫反应中起着复杂的作用.
结论:
- 准HMGCR-TNF-α轴为癌症治疗提供了一个有希望的途径.
- 开发新的HMGCR抑制剂或优化现有的可以提高抗瘤疗效.
- 基于机制的精密疗法有可能改善癌症治疗结果.
更多相关视频
06:38An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
9.4K
12:24A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
Published on: September 30, 2021
5.9K
相关概念视频
Cancer
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
Mouse Models of Cancer Study
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
